Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
32.42
+0.21 (0.67%)
At close: Jun 8, 2026, 4:00 PM EDT
32.39
-0.02 (-0.08%)
After-hours: Jun 8, 2026, 4:10 PM EDT
HRMY Market Cap
HRMY has a market cap or net worth of $1.88 billion as of June 8, 2026. Its market cap has decreased by -5.35% in one year.
Market Cap
1.88B
Enterprise Value
1.40B
1-Year Change
-5.35%
Ranking
Category
Stock Price
$32.42
Market Cap Chart
Since the IPO on August 19, 2020, HRMY's market cap has increased from $461.03M to $1.88B, an increase of 306.73%. That is a compound annual growth rate of 27.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 1.86B | -13.51% |
| Dec 31, 2025 | 2.16B | 9.82% |
| Dec 31, 2024 | 1.96B | 3.73% |
| Dec 29, 2023 | 1.89B | -42.12% |
| Dec 30, 2022 | 3.27B | 31.09% |
| Dec 31, 2021 | 2.49B | 21.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Trevi Therapeutics | 1.89B |
| Intellia Therapeutics | 1.89B |
| Iovance Biotherapeutics | 1.89B |
| Mesoblast | 1.88B |
| Stoke Therapeutics | 1.87B |
| Zai Lab | 1.87B |
| Lakefront Biotherapeutics NV | 1.86B |
| Vericel | 1.85B |